Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17183148rdf:typepubmed:Citationlld:pubmed
pubmed-article:17183148lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:17183148lifeskim:mentionsumls-concept:C0011570lld:lifeskim
pubmed-article:17183148lifeskim:mentionsumls-concept:C0289174lld:lifeskim
pubmed-article:17183148lifeskim:mentionsumls-concept:C0596902lld:lifeskim
pubmed-article:17183148lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:17183148lifeskim:mentionsumls-concept:C0678951lld:lifeskim
pubmed-article:17183148lifeskim:mentionsumls-concept:C0332125lld:lifeskim
pubmed-article:17183148pubmed:issue4lld:pubmed
pubmed-article:17183148pubmed:dateCreated2006-12-21lld:pubmed
pubmed-article:17183148pubmed:abstractTextPatients with Alzheimer disease (AD) often exhibit psychiatric symptoms associated with cognitive impairment. The serotoninergic system may be involved in the development of depressive symptoms in AD patients, as suggested by the evidence that antidepressant drugs having the serotonin transporter as their target are effectively used to treat depressive AD patients. The aim of this study was to investigate the role of serotonin in depression, searching for association of two serotoninergic polymorphisms (T102C of serotonin receptor 5-HT2A and serotonin transporter linked polymorphic region -5-HTTLPR- of SLC6A4 gene) with depressive symptoms and considering their possible interactions with Apolipoprotein E (ApoE) and between themselves, in a sample of 208 sporadic AD patients and 116 normal controls from Italy. 5-HTTLPR and T102C are not associated with AD when separately analysed. However, we found out an interaction between the two polymorphisms in L/L and C/C genotype carriers increasing the risk for the disease (p=0.015, OR=8.048; 95% CI: 1.497-43.262). No association of the polymorphisms was detected with depression linked to AD. No interaction between 5-HTTLPR and T102C was detected in depressive AD subjects, even after stratification according to the presence of ApoE4 allele. These results suggest that the serotoninergic system may be not involved in the pathogenesis of depressive symptoms in AD patients, and it may be involved in other aspects of disease pathophysiology like cognitive symptoms and psychosis.lld:pubmed
pubmed-article:17183148pubmed:languageenglld:pubmed
pubmed-article:17183148pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17183148pubmed:citationSubsetIMlld:pubmed
pubmed-article:17183148pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17183148pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17183148pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17183148pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17183148pubmed:statusMEDLINElld:pubmed
pubmed-article:17183148pubmed:monthDeclld:pubmed
pubmed-article:17183148pubmed:issn1387-2877lld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:MurriLLlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:RocchiAAlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:TognoniGGlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:MancusoMMlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:MichellAAlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:CeravoloRRlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:SicilianiMMlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:GennarelliMMlld:pubmed
pubmed-article:17183148pubmed:authorpubmed-author:BonviciniCClld:pubmed
pubmed-article:17183148pubmed:issnTypePrintlld:pubmed
pubmed-article:17183148pubmed:volume10lld:pubmed
pubmed-article:17183148pubmed:ownerNLMlld:pubmed
pubmed-article:17183148pubmed:authorsCompleteYlld:pubmed
pubmed-article:17183148pubmed:pagination371-8lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:meshHeadingpubmed-meshheading:17183148...lld:pubmed
pubmed-article:17183148pubmed:year2006lld:pubmed
pubmed-article:17183148pubmed:articleTitleNo evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease.lld:pubmed
pubmed-article:17183148pubmed:affiliationDepartment of Neuroscience, Neurological Clinic, University of Pisa, Italy.lld:pubmed
pubmed-article:17183148pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:348entrezgene:pubmedpubmed-article:17183148lld:entrezgene
entrez-gene:6532entrezgene:pubmedpubmed-article:17183148lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17183148lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17183148lld:entrezgene